Pluripotent stem cell derived cardiac cells for myocardial repair

Journal of Visualized Experiments

Volumn 2017, Issue 120, 2017, Pages

  Zhu, Wuqiang ^a   Gao, Ling ^a   Zhang, Jianyi ^a  

^a and Radiation Oncology   (United States)

Author keywords

Cell therapy; Developmental biology; Heart; Heart failure; Infarct; Issue 120; Myocardium; Pluripotent stem cells

Indexed keywords

ANIMAL; CARDIAC MUSCLE; CARDIAC MUSCLE CELL; CELL CULTURE; CELL DIFFERENTIATION; CELL SURVIVAL; CYTOLOGY; ENDOTHELIUM CELL; HUMAN; INDUCED PLURIPOTENT STEM CELL; METABOLISM; PATHOLOGY; PIG;

ANIMALS; CELL DIFFERENTIATION; CELL SURVIVAL; CELLS, CULTURED; ENDOTHELIAL CELLS; HUMANS; INDUCED PLURIPOTENT STEM CELLS; MYOCARDIUM; MYOCYTES, CARDIAC; SWINE;

EID: 85014400331     PISSN: 1940087X     EISSN: None     Source Type: Journal    
DOI: 10.3791/55142     Document Type: Article

References (21)

1. Qiao, H. et al. Death and proliferation time course of stem cells transplanted in the myocardium. Mol Imaging Biol. 11 (6), 408-414 (2009).
2. Ye, L. et al. Cardiac repair in a porcine model of acute myocardial infarction with human induced pluripotent stem cell-derived cardiovascular cells. Cell Stem Cell. 15 (6), 750-761 (2014).
3. Zhang, S., Dutton, J. R., Su, L., Zhang, J., & Ye, L. The influence of a spatiotemporal 3D environment on endothelial cell differentiation of human induced pluripotent stem cells. Biomaterials. 35 (12), 3786-3793 (2014).
4. Yang, L. et al. Differentiation of Human Induced-Pluripotent Stem Cells into Smooth-Muscle Cells: Two Novel Protocols. PLoS One. 11 (1), e0147155 (2016).
5. Rensen, S. S., Doevendans, P. A., & van Eys, G. J. Regulation and characteristics of vascular smooth muscle cell phenotypic diversity. Neth Heart J. 15 (3), 100-108 (2007).
6. Xu, C., Police, S., Hassanipour, M., & Gold, J. D. Cardiac bodies: a novel culture method for enrichment of cardiomyocytes derived from human embryonic stem cells. Stem Cells Dev. 15 (5), 631-639 (2006).
7. Anderson, D. et al. Transgenic enrichment of cardiomyocytes from human embryonic stem cells. Mol Ther. 15 (11), 2027-2036 (2007).
8. Huber, I. et al. Identification and selection of cardiomyocytes during human embryonic stem cell differentiation. FASEB J. 21 (10), 2551-2563 (2007).
9. Kita-Matsuo, H. et al. Lentiviral vectors and protocols for creation of stable hESC lines for fluorescent tracking and drug resistance selection of cardiomyocytes. PLoS One. 4 (4), e5046 (2009).
10. Choi, K. D. et al. Hematopoietic and endothelial differentiation of human induced pluripotent stem cells. Stem Cells. 27 (3), 559-567 (2009).
11. Woll, P. S. et al. Wnt signaling promotes hematoendothelial cell development from human embryonic stem cells. Blood. 111 (1), 122-131 (2008).
12. Li, Z., Hu, S., Ghosh, Z., Han, Z., & Wu, J. C. Functional characterization and expression profiling of human induced pluripotent stem cell-and embryonic stem cell-derived endothelial cells. Stem Cells Dev. 20 (10), 1701-1710 (2011).
13. Rufaihah, A. J. et al. Endothelial cells derived from human iPSCS increase capillary density and improve perfusion in a mouse model of peripheral arterial disease. Arterioscler Thromb Vasc Biol. 31 (11), e72-79 (2011).
14. Beauchamp, J. R., Morgan, J. E., Pagel, C. N., & Partridge, T. A. Dynamics of myoblast transplantation reveal a discrete minority of precursors with stem cell-like properties as the myogenic source. J Cell Biol. 144 (6), 1113-1122 (1999).
15. Qu, Z. et al. Development of approaches to improve cell survival in myoblast transfer therapy. J Cell Biol. 142 (5), 1257-1267 (1998).
16. Tang, X. L. et al. Intracoronary administration of cardiac progenitor cells alleviates left ventricular dysfunction in rats with a 30-day-old infarction. Circulation. 121 (2), 293-305 (2010).
17. Zeng, L. et al. Bioenergetic and functional consequences of bone marrow-derived multipotent progenitor cell transplantation in hearts with postinfarction left ventricular remodeling. Circulation. 115 (14), 1866-1875 (2007).
18. Davis, M. E. et al. Local myocardial insulin-like growth factor 1 (IGF-1) delivery with biotinylated peptide nanofibers improves cell therapy for myocardial infarction. Proc Natl Acad Sci U S A. 103 (21), 8155-8160 (2006).
19. Li, Q. et al. Overexpression of insulin-like growth factor-1 in mice protects from myocyte death after infarction, attenuating ventricular dilation, wall stress, and cardiac hypertrophy. J Clin Invest. 100 (8), 1991-1999 (1997).
20. Wang, L., Ma, W., Markovich, R., Chen, J. W., & Wang, P. H. Regulation of cardiomyocyte apoptotic signaling by insulin-like growth factor I. Circ Res. 83 (5), 516-522 (1998).
21. Chong, J. J. et al. Human embryonic-stem-cell-derived cardiomyocytes regenerate non-human primate hearts. Nature. 510 (7504), 273-277 (2014).